Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat vs Darbepoetin alfa in Incident Dialysis-Dependent CKD Anemia
NCT02865850Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- Jul 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of vadadustat in anemia, sponsored by Akebia Therapeutics. Started Jul 2016; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02865850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865850.